About Us

About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CareDx Fosters Transplant Innovation as Distinguished Founder’s Circle Sponsor for the 23rd Annual American Society of Transplant Surgeons State of the Art Winter Symposium

By: via Business Wire

CareDx Showcase Latest Innovations in Pre- and Post-Transplant Patient Care

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers -- today announced its leading participation and top spot, for the fourth consecutive year, as a Distinguished Founder’s Circle Sponsor for the 23rd Annual ASTS (American Society of Transplant Surgeons) State of the Art Winter Symposium, taking place January 12-15, in Miami, Florida.

“We take pride in our longstanding support of the American Society of Transplant Surgeons (ASTS) annual meeting, as it brings together world-class transplant leaders to drive the next wave of innovation to improve patient care,” said Reg Seeto, CEO and President of CareDx. “We look forward to being part of this important meeting and sharing our latest innovations in molecular surveillance and patient-centered digital health applications.”

CareDx will host a symposium highlighting the company’s latest scientific advancements in transplantation and digital health solutions to improve the pre- and post-transplant journey. The symposium, “From Benchtop to Bedside: Clinical Utility of Multi-Modal Molecular and Digital Tools” will be held on Friday, January 13, from 11-12 noon EST. Speakers include:

  • Titte "Srini" Srinivas, MD, MBA, FAST, Senior Vice President, Medical Affairs and Clinical Operations, CareDx
  • Steven R. Potter, MD, FACS, Transplant Surgeon, Georgetown University
  • Ali Zarrinpar, MD, PhD, Associate Professor, University of Florida
  • Vikas Dharnidharka, MD, MPH, Director, Division of Pediatric Nephrology, Hypertension and Pheresis, Professor of Pediatrics, Nephrology, Washington University in St. Louis, School of Medicine
  • Kenneth Chavin, MD, MBA, PhD, FACS, Director, Abdominal Organ Transplant Program, Professor of Surgery, Temple University

“CareDx has consistently demonstrated its commitment to driving innovation in the transplant field and we value their support as a Distinguished Founder’s Circle sponsor for our 23rd Annual ASTS State of the Art Winter Symposium,” said Dr. William C. Chapman, ASTS President and Chief of the Section of Transplant Surgery, Chief of Division of General Surgery and the Eugene M. Bricker Professor of Surgery at Washington University School of Medicine. “We also value their day-to-day contribution to improving the transplant patient journey and their dedication to advancing scientific research and digital health solutions aimed at improving long-term allograft outcomes.”

CareDx AlloMap® gene-expression profiling (GEP) was made commercially available in 2005 and AlloSure® donor-derived cell-free DNA (dd-cfDNA) in 2017, both becoming the most widely used non-invasive tests of their kind to identify immune quiescence and the risk of graft injury in transplant recipients. CareDx’s HeartCare is used in more than 90 percent of the nation’s heart transplant centers and in more than 1 in 2 newly transplanted patients.1 AlloSure Kidney is used in over 75 percent of kidney transplant centers and 1 in 3 newly transplanted patients.1 AlloSure Lung is used in over 60 percent of lung transplant centers and in 1 in 4 newly transplanted patients.1

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

Forward Looking Statements

This press release includes forward-looking statements related to CareDx, Inc., including statements regarding the potential benefits and results that may be achieved with CareDx’s leading participation as a Distinguished Founder’s Circle Sponsor for the 2023 American Society of Transplant Surgeons (ASTS) Symposium (the “ASTS Participation”). These forward-looking statements are based upon information that is currently available to CareDx and its current expectations, speak only as of the date hereof, and are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including risks that CareDx does not realize the expected benefits of its ASTS Participation; risks that the ASTS symposium, including the symposium and presentation hosted by CareDx, fails to take place on time, invite the speakers, or discuss the topics as stated in this press release; general economic and market factors; and other risks discussed in CareDx’s filings with the SEC, including the Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed by CareDx with the SEC on February 24, 2022, the quarterly report on Form 10-Q for the quarter ended March 31, 2022 filed by CareDx with the SEC on May 5, 2022, the quarterly report on Form 10-Q for the quarter ended June 30, 2022 filed by CareDx with the SEC on August 4, 2022, the quarterly report on Form 10-Q for the quarter ended September 30, 2022 filed by CareDx with the SEC on November 3, 2022, and other reports that CareDx has filed with the SEC. Any of these may cause CareDx’s actual results, performance, or achievements to differ materially and adversely from those anticipated or implied by CareDx’s forward-looking statements. CareDx expressly disclaims any obligation, except as required by law, or undertaking to update or revise any such forward-looking statements.

References:

  1. CareDx data on file.

 

Contacts

More News

View More
Caterpillar Stock Hits All-Time High—Is There More Room to Run?
Via MarketBeat
Topics Artificial Intelligence Economy World Trade
Tickers CAT
Berkshire-Backed Lennar Slides After Weak Q3 Earnings
Via MarketBeat
Topics ETFs
Tickers BRK-A BRK-B LEN
Analysts Turn Bullish on Hershey—Is Pepsi the Next Value Play?
Via MarketBeat
Tickers GS HSY PEP
Coming in Hot: Retail Data Drives Momentum in 3 E-Commerce Stocks
Via MarketBeat
Topics Economy
Tickers AMZN ETSY SHOP
MarketBeat Week in Review – 09/15 - 09/19
Via MarketBeat
Topics Economy
Tickers AAPL AMZN AVGO BE CRWD JOBY
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.